FOXC1 and acute myeloid leukemia: The consensus binding sites were overlaid with that identified from FOXC1-ChIP-seq binding data in an AML cell line (Fujioka cells)19 and revealed a slightly different consensus binding motif (Figure S3E), suggesting a degree of tissue/disease-specificity in FOXC1 binding sites (AML versus TNBC).